HIV/AIDS EOI revised
M
The following products were added:
News
S Kant’s sulfadoxine/pyrimethamine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Macleods’ flucytosine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl + amodiaquine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
S Kant’s dispersible isoniazid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
22nd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to su
First azithromycin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First NRT products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
ViiV Healthcare’s abacavir/dolutegravir/lamivudine pediatric dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First miltefosine prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First cefiderocol prequalified
M
WHO Prequalification Unit (PQT) added the below new p
Renata’s ethinylestradiol/levonorgestrel tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new p
Merck’s praziquantel prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First primaquine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zydus’ daclatasvir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Svizera’s isoniazid 300 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aurobindo’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shouguang Fukang’s sulfamethoxazole/trimetoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Cipla’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s pyridoxine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
First products for Ebola Virus Disease prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First bedaquiline product prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- TB396 - Bedaquiline fumarate - 100mg - Tablet - Lupin Ltd - INDIA
First paediatric abacavir/dolutegravir/lamivudine 60mg/5mg/30mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
Zhejiang Apeloa Kangyu’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Vaccines prequalification prioritity list 2024-2026
V
For more information click here